FTO inhibition could significantly increase the sensitivity of 5-FU in 5-FU-resistant colorectal cancer (CRC) cells via the FTO-SIVA1-YTHDF2 axis [84]. The gene discussed is FTO; the disease is colorectal carcinoma.